Hospitalisation rates with basal insulin in adults with T2D

Prescribing Information can be found through the links in the Product Cards at the bottom of the page

Hospitalisation³

Overall, a low number of episodes of hospitalised hypoglycaemia^‡ were observed in this study regardless of treatment.

The treatment persistence and hospitalisation retrospective analysis identified 181,263 people with T2D, newly treated with insulin in 2016-2017. The study used prescription claims data from the Système National des Données de Santé, a French administrative healthcare database.³

Persistence was defined as remaining on any basal insulin or on the same insulin without discontinuation from the index date to the last prescription. A therapy was deemed discontinued when it was interrupted for a period of 6 months.³ 

^‡Hospitalisations for severe hypoglycaemia and associated diagnoses were identified with ICD 10 codes.³

Diabetes Products